Get started
Author

Ömer Aydın Yıldırım

Observed names: Omer Aydin Yildirim, Yıldırım, Ömer Aydın, Ömer Aydın YILDIRIM
Institution: Sanko University
ORCID: 0000-0002-7503-6361
Observed ORCID: 0000-0002-7503-6361
OpenAlex ID: A5014887346
The C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index as an Independent Predictor of Progression and Survival in Metastatic Renal Cell Carcinoma
2026 · Beril Balci Topuz, Ahmet Tufekci, et al. · Journal of Clinical Medicine · 3
PDF
Real-world Outcomes of Second- and Third-line Therapies After First-line Vegfr-tki Failure in Metastatic Renal Cell Carcinoma: a Single-center Experience From Türki̇ye
2026 · Beril Balcı Topuz, Ahmet Tüfekçi, et al. · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi
CT-252 First 1-Year Results of a New Hematopoietic Stem Cell Transplant Center
2024 · Salih Sertaç Durusoy, Ömer Aydın Yıldırım, et al. · Clinical Lymphoma Myeloma & Leukemia
First 1-Year Results of a New Hematopoietic Stem Cell Transplant Center
2024 · Salih Sertaç Durusoy, Ömer Aydın Yıldırım, et al. · Clinical Lymphoma Myeloma & Leukemia
HMBG-1: A Biomarker in the Management of Diabetic Retinopathy
2024 · Burak Bilgin, Necla Benlier, et al. · Iberoamerican Journal of Medicine
The Diagnostic Importance of High Mobility Group Box-1 in Urine as a Tumor Marker in Prostate Cancer: Descriptive Research
2024 · Mehmet SOLAKHAN, Necla BENLİER, et al. · Journal of Reconstructive Urology
Bakteri̇yel Sepsi̇ste High Mobility Group Box Protein-1’i̇n Rolü
2021 · Yıldırım, Ömer Aydın, Benlier, Necla, et al. · Acta Medica Nicomedia
PDF
Works count: 7
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type